Document is current
Any future updates will be listed below
-
Authors
Nuttens, Charles https://orcid.org/0000-0001-6288-8023
Moyersoen, Juliette https://orcid.org/0009-0006-2477-677X
Curcio, Daniel https://orcid.org/0000-0002-3387-2433
Aponte-Torres, Zuleika https://orcid.org/0000-0001-5754-5026
Baay, Marc https://orcid.org/0000-0001-7266-551X
Vroling, Hilde https://orcid.org/0000-0002-5840-3676
Gessner, Bradford D. https://orcid.org/0000-0002-6216-7194
Begier, Elizabeth https://orcid.org/0000-0002-1287-5416
-
Funding
Funding for this research was provided by:
Pfizer Inc
- License Information
-
More Information
Article History
Received: 20 October 2023
Accepted: 21 June 2024
First Online: 6 July 2024
Declarations
:
: Juliette Moyersoen, Marc Baay, Zuleika Aponte-Torres, and Hilde Vroling are employees of P95, which received funding from Pfizer in connection with the development of this manuscript. JM owns shares in the GSK group of companies as part of her previous employee remuneration. Charles Nuttens, Daniel Curcio, Bradford Gessner and Elizabeth Begier are employees of Pfizer and may own Pfizer stock.
: This study is an integrative review of published data and, therefore, ethical approval was not required.
